Your browser doesn't support javascript.
loading
Renal toxicity of targeted therapies for renal cell carcinoma in patients with normal and impaired kidney function.
Mielczarek, Lukasz; Brodziak, Anna; Sobczuk, Pawel; Kawecki, Maciej; Cudnoch-Jedrzejewska, Agnieszka; Czarnecka, Anna M.
Afiliação
  • Mielczarek L; Department of Experimental and Clinical Physiology, Laboratory of Centre for Preclinical Research, Medical University of Warsaw, Warsaw, Poland.
  • Brodziak A; Department of Experimental and Clinical Physiology, Laboratory of Centre for Preclinical Research, Medical University of Warsaw, Warsaw, Poland.
  • Sobczuk P; Department of Oncology and Radiotherapy, Maria Sklodowska-Curie National Research Institute of Oncology, Warsaw, Poland.
  • Kawecki M; Department of Experimental and Clinical Physiology, Laboratory of Centre for Preclinical Research, Medical University of Warsaw, Warsaw, Poland.
  • Cudnoch-Jedrzejewska A; Department of Soft Tissue/Bone Sarcoma and Melanoma, Maria Sklodowska-Curie National Research Institute of Oncology, Warsaw, Poland.
  • Czarnecka AM; Department of Oncology and Radiotherapy, Maria Sklodowska-Curie National Research Institute of Oncology, Warsaw, Poland.
Cancer Chemother Pharmacol ; 87(6): 723-742, 2021 06.
Article em En | MEDLINE | ID: mdl-33768301

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Carcinoma de Células Renais / Rim / Neoplasias Renais / Antineoplásicos Tipo de estudo: Guideline / Screening_studies Limite: Animals / Humans Idioma: En Ano de publicação: 2021 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Carcinoma de Células Renais / Rim / Neoplasias Renais / Antineoplásicos Tipo de estudo: Guideline / Screening_studies Limite: Animals / Humans Idioma: En Ano de publicação: 2021 Tipo de documento: Article